Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4548 USD | +3.74% |
|
+41.02% | -16.29% |
Business Summary
Number of employees: 405
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Zinc Finger Protein
100.0
%
| 111 | 100.0 % | 176 | 100.0 % | +58.34% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 111 | 100.0 % | 176 | 100.0 % | +58.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 16-05-31 |
Director of Finance/CFO | 45 | 19-02-28 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 20-04-30 |
Phillip Ramsey
CTO | Chief Tech/Sci/R&D Officer | - | - |
Louise Wilkie
IRC | Investor Relations Contact | - | 20-08-31 |
Amy Pooler
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 19-08-31 | |
Scott Willoughby
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 22-12-14 |
James Meyers
BRD | Director/Board Member | 59 | 19-11-21 |
H. Parker
CHM | Chairman | 68 | 14-06-18 |
Kenneth Hillan
BRD | Director/Board Member | 63 | 20-09-10 |
Robert Carey
BRD | Director/Board Member | 65 | 16-05-31 |
Karen Smith
BRD | Director/Board Member | 56 | 18-06-27 |
Alexander Macrae
CEO | Chief Executive Officer | 61 | 16-05-31 |
John Markels
BRD | Director/Board Member | 58 | 20-02-10 |
Courtney Beers
BRD | Director/Board Member | 54 | 22-12-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 207,510,076 | 191,465,847 ( 92.27 %) | 0 | 92.27 % |
Company contact information
![address Sangamo Therapeutics, Inc.(SGMO)](https://cdn.zonebourse.com/static/address/10811.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.29% | 94.38M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- SGMO Stock
- Company Sangamo Therapeutics, Inc.